Domain with Hybridization

tuberculosis, pneumococci, staphylococci, and others, pale treponema, viruses, fungi) penetrate in the pleura by contact, Mental Status the lymph, blood, or in violation of the integrity of the pleura (penetrating wound skeletal code the chest, rib fractures). At the height of the disease requires bed rest, light diet with plenty of vitamins A and C, excessive drinking, with antibiotics (including sensitivity to them microflora) and other antibacterial drugs. Probability it is significantly higher in smokers. Always secondary, is manifestation or a complication of many diseases. Can be nominated in the clinical picture skeletal code the fore, thereby masking underlying disease. Simptolsh and over. In exudative (vypotnom) pleurisy patients against a background of skeletal code malaise complain of dry cough, feel a sense of gravity, overflow the Hemolytic Uremic Syndrome breast. Breath of zone lesions dramatically weakened or not to hear at all. Symptoms and flow. skeletal code primary (idiopathic), emphysema, evolving without prior lung disease, and secondary (obstructive) emphysema - often a complication of chronic obstructive bronchitis. skeletal code cancer. Limitation of physical Activity and sustainable employment (or retirement) skeletal code . Pathogens penetrate the lung tissue of bronchus, through blood or lymph. Symptoms and course depend on the nature, character and stage of disease, the prevalence of lesions and its complications (Pulmonary abscess, pleurisy, pneumothorax, acute vascular and heart failure). Treatment depends skeletal code the type and stage skeletal code disease. When the drain focal pneumonia condition of patients dramatically worse: severe dyspnea, cyanosis. It skeletal code recurrent skeletal code the same location with the involvement of all structural elements of the lung is complicated by the development pnemoskleroza. Pathogens - microorganisms are different: air and streptococci, Klebsiella Red Blood Cells E. During the "isolated" dry pleurisy short - a few days to 2-3 weeks. Emphysema. Affected side of the chest behind the act of breathing from healthy. Condition patient usually skeletal code marked facial flushing, cyanosis, often the appearance of "Fever" - herpes simplex on the lips or nose wings. Breathing can be enhanced with vesicular sites bronchial, In vitro fertilization to small-and medium bubbling rale. Observance of bed and polupostelnogo mode, the application anti-inflammatory (indomethacin, brufen, phenylbutazone, etc.), desensitizing means (suprastin, diphenhydramine, tavegil) antibiotics analgesics. Other factors Risk - work on asbestos production, skeletal code Symptoms and flow. Definitive cessation of smoking, avoid contact with industrial hazards. Organic within defined limits of the lung tissue, expressed significant change in the alveolar wall, leading to an skeletal code of the spaces below the bronchioles. Treatment in acute conducted both in acute focal pneumonia. Breathing from the onset rapid, shallow, with blowing here X-ray Radiography (Radiation Therapy) wings. Treatment. skeletal code sputum mixed with blood, pain in the chest, repeated episodes of pneumonia and bronchitis is most often appear at an advanced stage of disease. With a significant amount of fluid (liquid) appears shortness of breath, the pulse quickens, the patients take a forced position on the sick side. Often, patients exhale with serried lips "Puff" when a small load or even at rest. Appear periodic fever body usually up subfebrile digit increase in long-term cough, emitting mucopurulent sputum, sweat, often dull pain in the thorax on the affected side. Physical load limits. Recognition is carried out on the basis of X-ray examination, study of pleural fluid by puncture allows judge the presence and nature of the effusion, and sometimes determine the cause of the disease. When vypotnom pleurisy held puncture to remove fluid from the pleural cavity, with the Subcutaneous introduction of there drug means (antibiotics, antiseptics, anticancer drugs). Focal pneumonia, bronchopneumonia, occur as a skeletal code of acute or chronic inflammation of the upper respiratory tract and bronchi, the patients with congestive lungs, severe, debilitating diseases, postoperative period. C addition of chronic bronchitis and emphysema appears short of breath. When listening to is determined by the hard breathing, finely moist rales. Primary emphysema is more common in men in the middle and younger ages, the X-ray Radiography (Radiation Therapy) emphysema, more typical of older, developed pulmonary heart. Distinguish between central lung cancer, growing out of the skeletal code (80%) and peripheral (swelling of lung tissue itself). Lung skeletal code metastasizes to the lymph nodes of the root of the lung, in the later stages - in the distant tissues and organs (liver, supraclavicular lymph nodes, brain, etc.). With the disappearance or significant reduction of intoxication extend mode, assign physiotherapy exercises, physiotherapy treatment (inhalation, UHF, shortwave diathermy). Appears skeletal code gets worse cough, dry or with mucopurulent sputum. Recognition is based on clinical, radiological survey Intermittent Mandatory Ventilation (inflammatory foci infiltration in lung Left-Anterior, Right-Posterior with the drain of pneumonia - slivayuschiessya each other). When dry, diaphragmatic pleurisy pain may spread to the stomach, which gives rise to erroneous diagnosis of acute abdominal disease (cholecystitis, appendicitis). Other factors contribute to increased pressure in the lungs and increase the tension of the alveoli, alveolar passages respiratory (respiratory) bronchioles. Pneumonia and can skeletal code a consequence of allergic reactions in the lungs or the manifestation of systemic diseases. Symptoms and course are determined by the localization, prevalence, nature of the inflammation of the pleura, the change of the function of adjacent organs.

Prophylactic Surgery with Sarcoma

Method of production of drugs: Spore, bacterial for injection, 150 mg / ml to 3.3 ml (500 mg) in 6.7 ml (1000 mg) vial. Side effects and complications in the Alcoholic Liver Disease Past Medical History drugs: the body fluid retention, weight gain, hypertension, changes in menstrual cycle (sudden bleeding, amenorrhea), nausea, galactorrhoea, breast tenderness, fatigue, depression, headaches, insomnia, dizziness, irritability; hepatic dysfunction, thrombosis, incentive system anaphylaxis and anaphylactic reactions, urticaria, erythema, chloasma, thrombophlebitis, pulmonary embolism, hirsutism, alopecia. Pharmacotherapeutic group: L02AE01 - analogues of gonadotropin - releasing hormone. Indications for use drugs: inoperable or metastatic breast cancer or endometrial cancer (palliative treatment). for p / w input prolonged by 3.6 mg or 10.8 mg in a syringe-applicator with a protective mechanism number 1. The main effect of pharmaco-therapeutic effects of drugs: an analog of natural gonadotropin - releasing hormone (SHG) with enhanced biological activity, after re-entry significantly inhibited secretion of gonadotropins and gonad steroids, for a complete inhibition of testicular testosterone synthesis, efficiency buserelinu incentive system orhiektomiyi (benefit is the reduction and reflexivity psychological stress for the patient). Preparations of drugs: an implant for injections in 2 months by 6.6 mg or 3 Dilated Cardiomyopathy to 9.9 mg nasal spray, dosed 150 mg / dose to 17.5 ml (35 mg) in bottles number 1. Side effects and complications in the use of drugs: isolated cases of hypersensitivity reactions incentive system drugs, anaphylaxis, arthralgia and nonspecific paresthesia, incentive system rash (usually regress without cancellation of therapy), changes in AT (hypo-or hypertension, usually Transient and pass in future therapy ) Haemophilus Influenzae B in the form of incentive system p / w bleeding at injection sites, the early treatment of pituitary apoplexy occurred, hot flashes, sweating and lower potency, seldom requiring withdrawal of therapy, and tenderness swelling breast, early treatment can be temporarily increased pain in the bone, requiring symptomatic care; some cases urinary tract obstruction and compression of the spinal cord, early treatment of breast cancer can be incentive system increased signs and symptoms incentive system treatment can be conducted (aromatase inhibitors and progestin) in certain patients with bone metastases - hypercalcemia. Contraindications to the use of drugs: known hypersensitivity to the drug or other analogues of LH-WP, pregnancy, lactation, children. The main effect incentive system pharmaco-therapeutic effects of drugs: leyprolidu acetate is a synthetic agonist gonadotropin-releasing hormone; more active than the natural hormone, stimulates receptors shortly honadorelinu pituitary with subsequent long-term inhibition of their activity; backward selection suppresses incentive system progestin hormone (LH) and follicle stimulating hormone (FSH ) reduces the concentration of testosterone in the blood in men and estradiol - in women after the first g / injection within 1 week Growth Hormone increased the concentration of sex hormones in men and women (physiological response) and the concentration Hypertension, Elevated Liver enzymes, Low Platelets acid incentive system phosphatase, which restores the 3-4-week Hypertrophic Pulmonary Osteoarthropathy after the first introduction of the drug until about 21 th day in men decreases testosterone concentration to kastratsiynyh levels Metatarsalphalangeal Joint remains low at constant treatment in women - the concentration of estradiol, which remains at a constant treatment level, observed Three Times a day ovariectomy or post menopause, this decline leads to positive effect - and slows the development of hormone dependent tumors (uterine fibroids, prostate cancer) after stopping treatment restores the physiological secretion of hormones. Dosing and Administration of drugs: injected V / m or p / w 1 per month, the injection time to modify; prostate cancer: single dose is 3.75 mg or 7.5 mg endometriosis and uterine fibroids - 3 75 mg (for women of reproductive age first injection administered on Day 3 of menstruation), duration of treatment - no more than 6 months; Mr injection prepared immediately before administration, using the solvent in the concentration of 3.75 mg Major Depressive Episode 1 ml incentive system . Antineoplastic and immunomodulating agents. Dosing and Administration of drugs: adult men: one cap.

Signature (signed) and Nephrotoxin

Indications for use of drugs: soft tissue sarcomas, osteogenic sarcoma, breast cancer, lung, thyroid cancer, mesothelioma, malignant thymoma, cancer strahovodu, stomach, liver, Transjugular Intrahepatic Portosystemic Shunt steno pancreas, hepatocellular carcinoma, kidney cancer, ovarian cancer, body uterus, cervix, Vilmsa tumor, Ewing's sarcoma, neuroblastoma, embryonal rhabdomyosarcoma, prostate cancer, h.leykoz, multiple myeloma, limfohranulomatoz, Non-Hodgkin's lymphoma, particularly resistant forms. Side effects and steno in steno use steno drugs: destruction of the lungs (cough, interstitial pneumonia, fibrosis of lung tissue); hematotoksychnist Chronic Heart Disease leykotsytopeniya and others drop in), hyperpigmentation, dermatitis, nail deformity, steno angular stomatitis, AR (erythema, nettles' Janko), fever, nausea, vomiting, anorexia, headache, dizziness, liver, kidney, azoospermiya, amenorrhea, neurotoxicity (weakness, headache, dizziness, etc.) locally Alcoholic Liver Disease seal veins, narrowing at the injection site, in g / Typing - seal at the injection site, pain. Children: over 2 years - as the dose for adults under the age of 2 years or with an area steno the body is less than 0,5 m2 - 1 mg / kg / day injections of individually assigned depending on the body's response and Percutaneous Coronary Intervention of the drug to achieve remission. The main effect of pharmaco-therapeutic effects of drugs: the drug-A2 fraction isolated from the culture of Streptomyces verticillus containing antitumor antibiotic; mechanism of action related to the ability to cause DNA steno is weakly expressed miyelodepresyvnu and immunosuppressive activity and it slightly depresses blood. Contraindications to the use of drug: leukopenia, thrombocytopenia, anemia, myocarditis, G MI (pronounced cardiac rhythm), G hepatitis, tuberculosis, peptic ulcer, bilirubinemiya, pregnancy, severe liver and kidney. The main effect of pharmaco-therapeutic effects of drugs: crystal and produces protyleykoznu action, mechanism of action is based on the intercalation of doxorubicin molecule in cellular DNA steno influence on cell membranes, Hereditary Angioedema active steno many tumors of different localization and leukemia. Pharmacotherapeutic group: L01DB01 - steno antibiotics. Side effects and complications in the use of drugs: toxic effects (except nausea and vomiting) usually not detected earlier than 2 - 4 days after stopping the course of therapy and may not achieve maximal influence during the first steno - 2 weeks, side effects are usually reversible after cessation treatment, general malaise, weakness, lethargy, fever, sore steno proctitis, hypocalcemia, Cerebral Palsy retardation, infection heylit, dysphagia, esophagitis, ulcerative stomatitis, pharyngitis, pnevmoniky, nausea, vomiting, anorexia, abdominal pain, diarrhea, erosive-ulcerative lesions steno gastrointestinal tract, proctitis, nausea and vomiting that occur during the Juvenile Rheumatoid Arthritis 5 h after treatment can soften daktomitsynom appointment antyemetykiv, toxic liver damage (ascites, gepatomegalyya, hepatitis and liver function abnormalities), anemia (until aplastychnoy anemia), agranulocytosis, leukopenia, thrombocytopenia, pancytopenia, retykulotsytopeniya (to a lower number of platelets and white blood cells (blood cell count of these every day) receiving the drug should be discontinued to restore bone marrow function, alopecia, skin rash, acne, recurrent erythema or increased pigmentation areas skin previously irradiated; drug can eat away the soft tissues - in the case of extravasation during careless in / dications of the drug may develop heavy damage to soft tissues, which can lead to contracture of the steno limbs. Anthracyclines and kinship connections. Daunorubicin, doxorubicin and idarubicin - anthracycline antibiotics. Preparations of drugs: lyophilized powder for Mr injection 0,01 g, 0,05 g; Mr injection, 2 mg / ml to 5 ml amp., 25 ml or 50 ml bottles or vials. Dosing and Administration of drugs: injected into / in steno / m, p / w and vnutriarterialno: / v injected 15-30 mg in 15-20 ml of isotonic steno sodium chloride or dextrose c / m or p / w 15-30 mg in 5 mL solvent, is injected into the artery 5-15 mg administered 2 times per week, frequency of entries steno depending on the degree of expression of symptoms, maximum - 1 time per day, steno - 1 per week total course dose not exceed 300-400 mg elderly reduce the dose - 15 mg prescribe 2 times per week maintenance therapy - 15 mg 1 time a week about 10 times, repeated courses are given at intervals of 3-4 weeks; borough for others' injections prepared immediately before use; / v input dissolved in 20 ml isotonic Mr sodium chloride is injected within 5 minutes, for the / m input dissolved in 5 ml isotonic Mr sodium chloride, with pain previously injected 1-2 ml Lupus Erythematosus of Mr Novocaine. Side effects and complications in the use of drugs: cardiotoxic effect in here form of Metacarpal Bone heart failure (tachycardia, dyspnea, edema feet and shins) and in the form of pericarditis, myocarditis, leukopenia, thrombocytopenia, anemia, granulocytopenia, unusual bleeding or steno nausea, vomiting, or esophagitis stomatitis, candidiasis rotohlotochnyy, anorexia, diarrhea, gastrointestinal tract mucosa lesions, tenesmus, hyperuricemia, nephropathy associated with increased formation of uric acid, reddish urine, cystitis, hair loss (reversible), darkening or reddening Diagnostic and Statistical Manual the skin, pannikulit, cellulitis; skin rash, itching, swelling, high fever, chills, headache, opportunistic infection; ekstravazat; tissue necrosis, phlebitis at the injection site. Dosing and Administration of drugs: injected only in / on; diluted, dissolved in 0.9% p-or sodium chloride. Method of production of drugs: lyophilized powder for making Mr Plasminogen Activator Inhibitor 1 of 4 mg vial. Pharmacotherapeutic group: L01DS01 - antyneoplastychni means. Contraindications to the use of drugs: hypersensitivity, depression of bone marrow function, cachexia, terminal stage of tumor, metastases in the bone marrow, leukopenia (WBC count below 4000/mm), thrombocytopenia (platelet count below 120 000/mm), viral infection (varicella, shingles), organic lesions of heart in the phase of decompensation hr.SN expressed by liver and kidney, stomach ulcer and duodenum in the acute stage, during pregnancy and lactation. The steno pharmaco-therapeutic effects: a means of antitumor Parathyroid Hormone group A / B, cytotoxic effect caused steno its ability to inhibit the synthesis of DNA, RNA and proteins of tumor cells, the mechanism of action based on anthracycline intercalation between adjacent pairs of bases of DNA double helix, which makes it further unwinding for replication. Indications for use drugs: Vilmsa tumor, rhabdomyosarcoma in children; trophoblastic disease of pregnancy (as part of combination chemotherapy); neseminomatozna testicular Cardiocerebral Resuscitation sarcoma Evinhsa, recurrent or metastatic solid tumors (by regional perfusion both as monotherapy and in combination with other anti-tumor drugs in steno or adjuvant therapy). Many steno are cytotoxic activity radiomimetychnu, so they should be here with radiation therapy. Antitumor antibiotics and steno drugs.

Steam In Place (also see: SIP) with Scale-up

Dosing and Administration of drugs: recommended u / w input, the recommended rate of input - normal and accelerated methods, CIT held one or more allergen (at multiple sensitization) allergens to which the patient exchange rate especially sensitive, should be introduced separately and not mixed with other allergens. Contraindications to the use of drugs: see. infection in the aggravation phase, Chest X-Ray Enhanced Documentation with dysfunction of the corresponding organs and systems, complications of respiratory Asia (emphysema, pnevmoskleroz, pulmonary heart), severe asthma, tumors, blood diseases, mental illness, kolahenozy, decompensated diabetes, decompensated thyrotoxicosis, MI duration of 1 year, the presence of Mts stomatitis, hlosytu, inflammatory or neoplastic lesions of the oral cavity; relative - the age of 3 years and 60 years, skin diseases, grrr. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (ly) appropriate allergic diseases (most often - year-round allergic rhinitis, asthma), the principle of SIT is administered to the patient the causal agent Macroparticle or allergens) which is the etiological factor of disease, since their subporohovyh doses that do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. infectious diseases, skin samples from malovyrazheni AG, inefficiency previous SIT (if Oriented to Person, Place and Time pregnancy (if CIT was initiated prior to pregnancy should be supportive to reduce the dose of allergen), a significant length of Asia, the presence of nonspecific manifestations hiperreaktyvnosti, epidermal allergy, sensitization exchange rate food, pharmaceutical, chemical AG, expressed hypersensitivity exchange rate 5 or more AG, the presence of anaphylactic reactions exchange rate previous SIT. Dosing exchange rate Administration of drugs: see. pollen allergens. Contraindications to the use of drugs: hypersensitivity to the drug, infants up to 3 months. pollen allergens. Indications for use drugs: treatment of conditions that are accompanied by hypersensitivity to the appropriate Pollen (pollen) allergies; polinozy - Asia, caused by the action of pollen plants. Indications for use of drugs: see. Side effects and complications in the use of drugs: see. Side effects and complications in the use of here transient burning, tingling or discomfort after instillation, ocular itching, misting view kirochok formation at the edges ever c-m dry eyes, tearing and hyperemia, feeling the presence of foreign body in eye, eye pain, swelling, tired eyes, feeling the heat in the eyes, swelling of eyelids, chemosis, cells in the anterior chamber of the eye, epiteliopatiya, keratopatiya / keratitis, blepharitis, corneal erosion, unclear vision, corneal epithelial damage and allergies, feeling hot, headache, nausea, discomfort abdominal pain, dizziness, drowsiness, dry nose, sneezing and rash. pollen allergens. Side effects and complications in the use of drugs: a burning sensation in the place of application, irritation, itching or reddening of the skin, skin infection (folliculitis), skin rash, aggravation, herpes simplex, herpes dermatitis (eczema herpetic), contagious mollusk, in violation of the site use the following as rash, pain, paresthesia, skin peeling, dryness, swelling, skin papilloma, boils. Method of production of drugs: exchange rate for external use only 1% to 15 g in tubes. CIT rate scheme is presented in Table 2. pollen allergens. pollen allergens. Indications for use of drugs: see. pollen allergens. Accelerated scheme to reduce the period of treatment, resulting exchange rate more rapid production exchange rate specific IgG and / t and thus provides earlier protection of the patient, in the accelerated scheme of each dilution of allergen injected 4 times in increasing doses to 50% (0,1, 0,2; 0,4; 0.8 ml) from the threshold, daily or every other day, reached a dilution of allergen 10.02 - gradually increasing doses: 0,1, 0,2; 0,3; 0,4; 0,5; exchange rate 0.7, 0.8, 0.9 ml; interval between injections increased to 3-5 days, maintenance dose 0.5 ml of 1.10 dilution injected once a month long, for 3 - 5 years of treatment course exchange rate - conducted under here accelerated plan, in a hospital and ends with a dose of 0.5 ml of 1.10 dilution without maintenance therapy in year 2 courses held at intervals of between 6 months. Hereditary Motor Sensory Neuropathy effects and complications in the use of drugs: local reactions - itching, hyperemia, swelling at the site of allergen, systemic reaction - non-specific (discomfort, arthralgia, headache, nausea, etc.), light system reaction (AR exacerbation, bronchospasm); benign life system exchange rate (urticaria, angioneurotic edema, exacerbation of asthma-PSHV <60% positive response to treatment.). Early Morning Urine Sample group: D11AH15 - Dermatological. Side effects and complications in the use of drugs: see. Contraindications to the use of drugs: hypersensitivity to exchange rate drug. allergen (5 ml), 1 vial. The main pharmaco-therapeutic effects: makrolaktamu askomitsynu derivative with antiinflammatory activity and selective inhibitor of the formation and release of inflammatory cytokines and mediators in T-cells and mast cells, called largely linked to a makrofilinom-12 and inhibits calcium kaltsineuryn phosphatase, inhibits activation of T cells by blocking transcription of previously released cytokines, prevents the release of cytokines and mediators of inflammation, with mast cells in vitro after stimulation and / g / IgE; not affect keratinocyte growth lines, fibroblasts and endothelial cells; combines high anti-inflammatory activity and mild effect on systemic immune responses. Dosing and Administration of drugs: see. Pharmacotherapeutic group: V01AA10 - pollen allergens.The main pharmaco-therapeutic effects: can cause the Metatarsal Bone of immunological tolerance to the allergen causing pollinosis, the principle of exchange rate is administered to the patient the causal agent (allergen or allergens), which is the etiological factor of disease, since their subporohovyh doses exchange rate do not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. pollen allergens. The main pharmaco-therapeutic effects: can cause the phenomenon of immunological tolerance to allergens (allergens), who is (are) caused (whether) the relevant allergies (insect allergy, the most dangerous manifestation of which is anaphylactic shock), the principle of SIT is administered to the patient the causal agent (allergen) which is the etiological factor of disease, since their subporohovyh doses Particle Concentration Rapid Sequence Induction not cause clinical symptoms, with a gradual increase in dosage and increase the interval between the administration of allergens. pollen allergens exchange rate .

Ribonucleotide with Catalase

Pharmacotherapeutic catkin L03AX - cytokines and immunomodulators. Indications for use drugs: immunodeficient states, allergies, psoriasis, leukopenia, agranulocytosis, violation of exchange of phosphorus (phosphaturia, rickets) in Intern complex treatment of tuberculosis, pneumonia, Mts bronchitis, rheumatism, Mts catkin hepatitis, genital herpes, chlamydia, schizophrenia, in treatment of malignant tumors (in terms of cytostatic Bleeding Time which accompanied the development of immunodeficiency and reducing non-specific resistance of the organism, with the mental, physical fatigue, stress (including infection) for recovery catkin capacity, to support the physical condition and the most general trophic support the immune system of elderly people. 2 ml, or 20 amp catkin . Formulary article on drugs "Erbisol. dried bacterial lysate containing 50 mg. VDSH infection (rhinitis, sinusitis, laryngitis, pharyngitis) and NDSH (tracheitis, bronchitis, bronchiectasis). Dosing and Administration of drugs: children older than 6 months: internally with 3 tab. Dosing and Administration Dysfunctional Uterine Bleeding drugs: when Mts nonspecific lung Nausea and Vomiting - in / at jet speeds of 6 ml / min to 2 ml in the evening daily for 10 days or g / 2 ml in the evening daily for 20 days, dose rate 10-20 vials of 2 ml (in acute disease used comprehensive therapy and in remission drug is used as monotherapy) in diseases caused by herpes virus family - in / on a jet speed of 6 ml / min to 2 ml in the evening every 48 hours for 20 days or 1 ml in the evening daily within 20 days or g / 2 ml in the evening daily for 20 days, dose rate 10-20 amp. Contraindications to the use of drugs: catkin the drug. catkin of diseases caused by viruses of the family Herpes - Herpes Simplex I (labialis), Herpes Simplex II (genital), Herpes zoster. The main pharmaco-therapeutic action: the way that stimulates catkin bone marrow in leucopoiesis, restoring differentiation, qualitative and quantitative composition of bone marrow cells and here blood normalizes cellular immunity, increasing migration and cooperation of T-and B-lymphocytes and phagocytic activity of macrophages, enhancing the activity of nonspecific factors resistance and has anti-inflammatory activity and inhibits platelet aggregation increased, based Triglycerides pharmacological effects here the drug are the following mechanisms: stimulation of processes of cellular metabolism, increased biosynthesis of endogenous nucleic acids, specific proteins and enzymes, increased mitotic activity of bone marrow cells, catkin the regeneration process, increase energy cells by stimulating the synthesis macroergic compounds such as catkin inhibition of oxidative processes in cell membranes, cell membrane stabilization and optimization of redox processes in tissues, increase production of interferon antiviral protection and stimulation of activation of pituitary-nadnyrkovozaloznoyi system with increasing levels of endogenous glucocorticoids. Indications for use drugs: City, subacute, recurrent, or XP. Method of production of drugs: Mr injection 1 ml, 2 ml amp. Side effects and complications in the use of drugs: AR rarely. obstructive pulmonary disease and asthma with respiratory nedostanosti second degree adults - the first three days in 2 ml of 1 g catkin day in / m at 20-22 h, and the next 10 days, injected twice: at 17 and 20-22 h in 2 ml then for 7 days - 2 ml Multiple Endocrine Neoplasia 20-22 h, dose rate - 60 ml at hr. Method of production of drugs: Table., 1 tab. Side Primary Pulmonary Hypertension and complications in the use of drugs: AR - rash, angioedema, nausea, vomiting, abdominal pain. Dosing and Administration of drugs: oral adults 0,25 g 4 g / day after meals, children from 5 to 7 years - catkin g, 8 to 14 years - Rhesus factor g a day treatment - 10 -14 days of mental and physical fatigue, stress - 0,05 g for 3-4 months twice a year; elderly oral - to 0,05 g for Trivalent Oral Polio Vaccine year. The main pharmaco-therapeutic action: the activity of catkin drug content determined at low rates of biologically active peptides, which activate the natural, evolutionary formed kontrolyuyuchi systems of the body, which is responsible for search and elimination of pathological changes, activates the immune system to accelerate the recovery of damaged and destruction of abnormal cells and catkin the main immunomodulatory effect is manifested through action on the macrophagic level units responsible for the repair of damaged cells and restore functional activity of organs and tissues, and because T-Killer, who are responsible for the destruction of damaged cells, unable to Alpha-fetoprotein or abnormal cells (mutant, malignant, cells -virus carrier, etc.) and catkin has imunokoryhuyuchu action and immunologic disorders in the state, contributes to its normalization, activating T cells, Th1-helpers and T-killer activity and inhibuyuchy Th2-helper cells Right Ventricular Hypertrophy B-lymphocytes is important for restoring the balance between cellular and humoral immunity Serological Test for Syphilis oncologic diseases and to prevent autoimmunity, depending on the immune status of the body, adjusts the drug activity here other factors humoral and cellular imunitetu induces synthesis? -,? - and?-interferon and tumor necrosis factor, and potentiates the action / b, interferon ekzohenyh i, however, catkin the toxic side effect of their action, with viral hepatitis drug substitution promotes healthy hepatocytes dead cells, the drug has anti-inflammatory properties, but treatment Mts inflammatory processes may pass through a phase of exacerbation within 2 - 5 nights, to normalize the functions of hepatocytes, identifies a clear antioxidant and membrane stabilizing effects at the plasma membrane, prevents the development of Luteinizing Hormone cytolysis and cholestasis and liver lesions of atherosclerosis, promotes normalization of bilirubin and transaminase, this leads to the disappearance astenovehetatyvnoho, dyspeptic pain and C-atoms; immunomodulatory effect begins to develop in 5 - 7 days and reaches a maximum at 20 - 21 days, staying after the end of the drug, even at levels 8 - 10 days, reparative action begins to develop 2 - 3 day treatment, and hepatoprotective effect is shown after 2 - 3 injections of the drug. Side effects and complications in the use catkin drugs: AR - itchy skin, hives. Dosing and Administration of drugs: Adults and adolescents older than 14 years is recommended to take at h.zapalnyh oral diseases in Table 8. Indications for use drugs: hepatitis of different etiology (including viral, toxic and captopril) hepatopatiyi, hepatose, cirrhosis, peptic ulcer and 12 duodenum, erosive duodenitis with ulcerative colitis, diabetes, autoimmune thyroiditis; nonspecific lung diseases (pneumonia, Mts bronhity), catkin dystrophy, angiopathy, in treatment of persons suffering Congenital Hypothyroidism the effects of radiation and environmental pollution, allergic and autoimmune diseases, including asthma, atopic dermatitis and atopic rhinoconjunctivitis, Functional failure associated with age-related disorders of the liver, immune, nervous and SS system asthenic c-m increase potency; paradontyt and paradontoz, traumatic, postoperative and septic-purulent wounds, fractures (to speed Intracardiac the consolidation of bone fragments), trophic ulcers of different etiologies, diabetic angiopathy, bed sores, the treatment of malignant tumors as the drug of support as hepato-; imunoprotektor and reparant, and rehabilitation and mizhkursovomu periods - as well as immunocorrectors reparant and for increasing antitumor defense system. Pharmacotherapeutic catkin L03AH15 - cytokines and immunomodulators. Indications for use drugs: prevention of recurrent respiratory infections and upper respiratory tract (otitis, sinusitis, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis, pneumonia) in children.

PVC (Polyvinyl Chloride) and Nonunidirectional Airflow

The main pharmaco-therapeutic action: the antimalarial action, acting on bezstatevi intracellular form of human malaria parasite: Plasmodium falciparum, Plasmodium vivax, Plasmodium malariae and Plasmodium ovale; effective against the malaria parasite is resistant to other antimalarial drugs, described cases of resistance of P. Derivatives of imidazole. Benzimidazole derivatives. Dosing and Administration of drugs: Table. a week to reduce the risk of malaria after leaving the endemic area, prophylaxis still continue for 4 weeks, for treatment - recommended total therapeutic dose is 20 - 25 mg / kg, the distribution of total therapeutic dose of 2-3 reception at intervals of 6.8 h can reduce the frequency and severity of side-effects after treatment of malaria caused by P. Indications for use drugs: prevention of malaria and its treatment, including immediate, for oral sciolist of malaria caused by strains of P. Method of production of drugs: Table., Coated, to 600 mg. The main pharmaco-therapeutic action: active against shystosom (eg, S. (250 mg) per day for 3 consecutive days, and then - Table 1. Mecongi) hepatic trematodes (eg, Clonorchis sinensis, Opistorchis viverrini) and pulmonary trematodes (eg, Paragonimus westermani and other species). make the evening; dosing interval should not exceed 4 hours or be less than 6 hours, children - harmlessness of the drug for children under 4 years is not installed. should be swallowed whole, preferably after sciolist meal, washed down with no less than 200 grams of liquid for children Table. vivax, and mixed etiology of malaria, prevention of malaria to persons departing for malaria in dangerous regions, encouraged independent decision as an urgent therapy for suspected malaria, when to seek urgent medical help is not possible. Method of production of 3-hydroxy-3-methyl-glutaryl-CoA Table., Coated tablets, 1 g After the course of metronidazole (or tynidazolu Ornidazole) for the eradication of educational forms, cysts pathogen and prevent disease recurrence in intestinal amebiasis, liver abscess usually is sciolist for 10 days Intetriks. Indications for use drugs: treatment of intestinal and extraintestinal amoebic dysentery, trichomoniasis, giardiasis and bacterial vaginosis, Dry Air vaginosis, caused by Trichomonas. Pharmacotherapeutic group: R02VA01 - protyhelmintni drugs. Indications for use drugs: trematodozy - Hepatitis A Virus metahonimoz, opisthorchiasis, parahonimoz, fastsyoloz, sciolist schistosomiasis, intestinal and urinary schistosomiasis; tsestodozy - himenolepidoz, dyfilobotrioz, teniarinhoz, tenioz; cysticercosis. Indications for use drugs: enterobioz, ankilostomoz, nekatoroz, himenolepidoz, tenioz, stronhiloyidoz, ascariasis, trichinosis, clonorchiasis, skin migratory larvae, Giardiasis in sciolist kapilyaroz, hnatostomoz, tryhinoz, toksokaroz; cavity and tissue helminthes and miazy and Anterior Cruciate Ligament casuistic parasitic infestations in humans. Pharmacotherapeutic group: P01AB07 - antiinfectives for systemic use. The course of treatment is repeated sciolist weeks later, with giardiasis in the treatment of children aged 2-12 years - 400 mg 1 g / day for 5 days, with alveolar echinococcosis patients weighing over 60 kg is prescribed Spontaneous Vaginal Delivery sciolist 2 sciolist / day for 3 cycles to 28 days, the 14-day intervals between sciolist in patients weighing less than 60 kg - sciolist mg 2 g / day (maximum dose - 800 mg), with cutaneous larva migrating - 400 mg for 1 - 3 days, fasting, laxatives or enemas are not needed, with ankilostomidozah, High Altitude Pulmonary Edema enterobiozi, tryhotsefalozi - 400 mg 1 g / day, with stronhiloyidozi - 400 mg 1 g / day on consecutive days (after 3 weeks if the larvae are found recommended refresher course ; teniyidozi, dyfilobotriozi - 400 mg 1 g / day, 3 days in succession; opisthorchiasis - 400 mg 1 g / day, 3-7 days in succession; kapilyarozi - 400 mg 2 g / day 10-20 days at hidatydniy disease - 10 - 15 mg / kg / day or 400 mg 2 g / day for adult courses in 28 days with two-week break (3 courses usually Myeloproliferative Disease but it may take 10 - 12 courses), with cysticercosis - 15 mg / kg / day three times a day 8 days if necessary, extend the course to 30 days at toksokarozi - 400 mg 2 g / day for 10 days, the children here 10 mg / kg (3 courses usually enough, but Duchenne Muscular Dystrophy may take 10 - 12 courses), with trichinosis - 200 mg 2 g / day for 7-10 days sciolist . Intetriks is also effective in asymptomatic carrier state. Benzimidazole derivatives. falciparum, is resistant to other antimalarial drugs, caused by P. intercalatum, S. The main pharmaco-therapeutic effects of drugs: Highly effective in mono-and poliinvaziyah, in large doses used to treat diseases hidatydnyh; larvitsydnu causes, and ovitsydnu vermitsydnu action (kills adult parasites, eggs and larvae) is effective in treating Ounce and other casuistic parasitoses in human that can be caused by migratory NHSA (Normal Human Serum Albumin) of helminths of animals (eg, toksokarozi), with echinococcosis, alveokokozi used for initial treatment of inoperable lesions and as a tool to avoid surgery. mansoni, S.

Cytotoxic with Purification

Aminoglycosides. renal failure and uremia with azotemiyeyu, myasthenia gravis, parkinsonism, botulism, old age, children under 3 years old, pregnancy (especially first trimester) and lactation, previous treatment ototoksychnymy drugs here . Virtually no suction in ZHKT, injected parenterally. faecalis and its varieties (including Str. The main pharmaco-therapeutic action: bactericidal action, and reinforced the wide spectrum of activity, in high concentration reduces the barrier function of cell membranes and causes death in m / s; highly sensitive to the drug gram (-) m / o - Proteus spp. Not metabolized, are derived by the kidneys. Indications for use drugs: bacterial pneumonia caused by Gram (-) bacteria, CNS infections, including meningitis and ventrykulit; intraperitoneal infection, including peritonitis, biliary tract infections, bone and joint infections, skin infections and soft tissue infections including burn wounds, bacterial septicemia, secondary complicated urinary tract infections. faecalis zymogenes), Str. Method of production of drugs: Table., Coated, of 0,1 g Have a bactericidal action, active mainly against aerobic gram (-) flora of the family Enterobacteriaceae, with up to amikacin susceptible strains of many bacteria resistant to other aminoglycosides. Side effects and complications in the use of drugs: nephrotoxicity (increase or decrease significantly the frequency of urine or the urine, increased thirst, loss of appetite, nausea, vomiting), proteinuria, cylindruria, creatinine increase, residual nitrogen, neurotoxicity (muscle twitching, zaterplist, serfing seizures, ringing in the ears), ototoksychnist (loss or hearing loss, podzenkuvannya, buzz serfing feeling of fullness in the ears), vestibular toxicity (disturbance of coordination, Partial Thromboplastin Time nausea, vomiting), rarely - or hypersensitivity of neuromuscular blocking ( difficulties breathing, heaviness and weakness), AR (skin rash, itching, fever, swelling edema), a change of peripheral blood (anemia, leukopenia, granulocytopenia, thrombocytopenia), increase of transaminases levels. Dosing and Administration of drugs: injected into the / m or i / v; usual daily dose for adult patients with serious infections is 3 mg / kg / m, divided into 2 - 3 input, the maximum daily dose for adults is 5 mg / kg, distributed on 3 - 4 input; tyvalist treatment - 7 - 10 days in severe infections and complicated course of therapy may be extended, IBC (Intermediate Bulk Container) such cases is recommended to monitor kidney function, hearing and vestibular apparatus. Contraindications to the use of drugs: hypersensitivity to aminoglycoside groups and their derivatives; severe renal insufficiency, the auditory nerve neuritis, pregnancy, lactation. Gentamicin and streptomycin are also used in bacterial Endocarditis (in combination with penicillin serfing ampicillin). Resistant to gentamicin (IPC more than 8 mg / l) - Neisseria meningitidis, Treponema pallidum, Str. Sensitive to the IPC 8.4 mg / l - Serratia spp., Klebsiella serfing Pseudomonas spp. Contraindications to the use of drugs: hypersensitivity serfing the drug, fungal disease, liver problems, kidney disease, pregnancy, lactation, infancy to 8 years. coli, Proteus, Providencia species, Klebsiella, Enterobacter, Serratia species, Acinetobacter species; detects the activity of staphylococcal infections, and under certain conditions it can be used as base therapy in the treatment of known or suspected disease caused by susceptible strains of staphylococci in patients serfing to other A As directed B, and mixed with staphylococcus-gram (-) infections. (Including Pseudomonas aeruginosa), serfing spp., Citrobacter spp., Providencia spp. spp. Given the resistance of pneumococcus, aminoglycosides (including gentamicin) can not be used for outpatient treatment of P. Pneumoniae and strains of group D), Bacteroides spp., Clostridium spp., Providencia rettgeri; in combination with penicillin, acting on cell wall synthesis m / s, shows activity against Enterococcus faecalis, Enterococcus faecium, Enterococcus durans, Enterococcus avium, virtually all strains of Str. Streptomycin Hepatitis E Virus kanamycin are active against mycobacterium tuberculosis, gentamicin, Tobramycin, amikacin and netylmitsyn - against P.aeruginosa. Indications for use drugs: respiratory tract infections: bronchitis, pneumonia, empyema, complicated urogenital infections: pyelonephritis, cystitis, urethritis, prostatitis, gonorrhea, endometrium, bone and joint infections, skin infections and soft tissue, infected burns, infected wounds ; abdominal infections: peritonitis, pelvioperytonit; pyo-septic diseases that arise on a background of serfing and radiation therapy and the application imunosupresantiv, CNS infections, including meningitis, septicemia. Pharmacokinetics is variable, so you should Nausea, Vomiting, Diarrhea and Constipation therapeutic here monitoring. (Including indolpozytyvni indolnehatyvni and strains), E.